Trial Profile
Compassionate Use of Fedratinib for Patients Who Have Previously Received TG101348, SAR302503 or Fedratinib
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Jul 2020
Price :
$35
*
At a glance
- Drugs Fedratinib (Primary)
- Indications Myelofibrosis
- Focus Expanded access; Therapeutic Use
- Sponsors Celgene Corporation
- 05 Nov 2018 New trial record